Researchers at the University of Washington have developed a diagnostic platform that leverages the lateral flow immunoassay concept using quantum dots, a mobile phone, and an ultraviolet light-emitting diode.
To identify the superbug, the firm used a rapid test that assigns microbial DNA fingerprints to reveal the clonal identity of a bacterial strain in patient samples.
MyGene2 holds cases from 1,225 families, submitted by 880 user accounts, which include 723 unique genes, among them many new disease genes.
Despite years of experience of returning genetic test results, clinicians and researchers are still faced with many questions, such as what to do about VUS and secondary findings.
University of Washington scientists found that by adding a material first isolated from shellfish, they could increase the sensitivity of standard bioassays by up to 1,000 times.
PerkinElmer may be nearing an FDA submission for a panel based on technology from the University of Washington, amid a push for state-mandated screening programs.